Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Case Report
2008:74:4;375-378
doi: 10.4103/0378-6323.42916
PMID: 18797062

Homocystinuria due to cystathionine beta synthase deficiency

T Narayana Rao, K Radhakrishna, TS Mohana Rao, P Guruprasad, Kamal Ahmed
 Department of Dermatology, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India

Correspondence Address:
T Narayana Rao
Prof. and HOD of Dermatology, 15-14-15, Doctor`s Enclave, Near collectors office, Opp. Sagar Lodge, Visakhapatnam - 530 002
India
How to cite this article:
Rao T N, Radhakrishna K, Mohana Rao T S, Guruprasad P, Ahmed K. Homocystinuria due to cystathionine beta synthase deficiency. Indian J Dermatol Venereol Leprol 2008;74:375-378
Copyright: (C)2008 Indian Journal of Dermatology, Venereology, and Leprology

Abstract

A two year-old male child presented with cutis marmorata congenita universalis, brittle hair, mild mental retardation, and finger spasms. Biochemical findings include increased levels of homocysteine in the blood-106.62 mol/L (normal levels: 5.90-16mol/L). Biochemical tests such as the silver nitroprusside and nitroprusside tests were positive suggesting homocystinuria. The patient was treated with oral pyridoxine therapy for three months. The child responded well to this therapy and the muscle spasms as well as skin manifestations such as cutis marmorata subsided. The treatment is being continued; the case is reported here because of its rarity. Homocysteinuria arising due to cystathionine beta-synthase (CBS) deficiency is an autosomal recessive disorder of methionine metabolism that produces increased levels of urinary homocysteine and methionine It manifests itself in vascular, central nervous system, cutaneous, and connective tissue disturbances and phenotypically resembles Marfan's syndrome. Skin manifestations include malar flush, thin hair, and cutis reticulata / marmorata.
Keywords: B6 responsiveness, Cystathionine beta-synthase, Cutis marmorata.

Introduction

Homocysteinuria due to cystathionine beta-synthase (CBS) deficiency is an autosomal recessive disorder of methionine metabolism that produces increased levels of urinary homocysteine and methionine. [1] It manifests itself in vascular, central nervous system (CNS), and connective tissue disturbances and phenotypically resembles Marfan′s syndrome. Skin manifestations include malar flush easily seen after vigorous exercise or after exposure to the cold, livedo reticularis on the extremities, and thinning and diffuse hypopigmentation of the hair. CNS manifestations include mental retardation, grand mal seizures, depression, chronic behavioral disorders, obsessive compulsive disorders, and personality disorders. Cardiovascular system manifestations include thrombosis of both veins and arteries; ocular manifestations include progressive ectopia lentis, detachment of the retina and sclera, and significant myopia. Skeletal manifestations include limitation of joint mobility and osteoporosis. Other manifestations include pancreatitis, pseudocysts, and colicky abdominal pain. Untreated homocystinuria leads to systemic and ocular complications that can be prevented with early treatment. Therapeutic response depends on B6 responsiveness. Complications of homocysteinuria including ectopia lentis, thrombosis, and spinal osteoporosis are less severe with B6-responsive patients.

Case Report

A two year-old male child [Figure - 1], the product of a consanguineous marriage, presented with delayed developmental milestones, cutis marmorata congenita universalis [Figure - 2], brittle hair, mild mental retardation, and finger spasms. There were no hair shaft abnormalities and no facial dysmorphism.

Biochemical tests such as the silver nitroprusside and nitroprusside tests were positive, suggesting homocysteinuria. Biochemical findings include increased levels of homocysteine in the blood-106.62 µmol/L (normal levels: 5.90-16 µmol/L). The thyroid profile and blood counts were within normal limits.

The child was treated with daily oral Vitamin B6 (Pyridoxine) 50mg and folic acid 10mg for three months and a one time dose of Vitamin B12-1000 µg. The child responded well [Figure - 3] to this therapy over a period of three months with subsidence of the muscle spasms and skin manifestations such as cutis marmorata; the treatment is being continued.

Discussion

Differential diagnosis of homocystinuria includes Marfan syndrome and sulfite oxidase deficiency. Individuals with sulfite oxidase deficiency and Marfan syndrome have normal concentrations of plasma homocystine, total homocystine and methionine.

Increased concentrations of homocysteine or methionine also occur in several other biochemical genetic disorders. [2],[3],[4],[5] Homocysteinuria is a biochemical abnormality, not a specific disease entity. By far, the most common cause of this disease is a defect in the enzyme, cystathione beta-synthase (CBS) because of recessive mutations in its gene. Less common causes of homocysteinuria are defects in 5,10-Methylene tetrahydrofolate reductase activity-a heritable vitamin B12 deficiency as a result of absorption abnormalities (Imerslund syndrome) and transcobalamine deficiency, leading to defective cellular uptake of vitamin B12 [Figure - 4]. [6]

The major clinical manifestations of CBS deficiency include dolichostenomelia, ectopia lentis, chest and spinal deformities, skin manifestations like malar flush, thin hair, and cutis reticulata / marmorata. As homocysteinuria is a treatable disease, it should be included in the differential diagnosis of Marfan′s syndrome, thromboembolism, and severe psychomotor retardation.

The mechanism underlying the cutaneous manifestations of homocysteinuria is not clearly known. When a neonate is exposed to low environmental temperatures, an evanescent, lacy, reticulated red and blue cutaneous vascular pattern known as cutis marmorata appears over most of the body surface. It is a vascular change representing an accentuated physiological vasomotor response and it disappears over time. Persistent and pronounced cutis marmorata occurs in Menkes disease, familial dysautonomia, Cornelia de lange, Down′s syndrome, Trisomy 18 syndromes and in homocysteinuria.

Two types of homocysteinuria have been reported based on its treatment: one is B6-responsive while the other is not. Treatment of B6-responsive patients includes a combination of folic acid, vitamin B12, and pyridoxine, which significantly reduces homocysteine levels. [7],[8],[9],[10],[11] Treatment of B6-nonresponsive patients includes lowering of urinary levels of homocysteine and its disulphide derivative, as well as adherence to a methionine-restricted diet. Methionine levels increase over baseline with betaine therapy, but usually remain at levels that are not associated with adverse effects. Our case was B6-responsive and responded well to three months of pyridoxine therapy.

The principles of treatment are to correct the biochemical abnormalities, especially to control the elevated plasma homocystine concentration as much as possible and to prevent or at least reduce, the complications of homocysteinuria [12] and to prevent further complications such as thrombosis. The best results occur in those individuals identified by the newborn screening program, who are treated shortly after birth to maintain the plasma homocystine concentration < 11 µmol/L

Treatment with pyridoxine at a dose of approximately 200 mg/day should be given to those who have been shown to be B6-responsive. Pyridoxine may also be included in treatment despite evidence of B6-nonresponsiveness, typically in doses of 100-200 mg daily.

The majority of B6-responsive individuals also require a protein-restricted diet for metabolic control. B6-nonresponsive neonates require a methionine-restricted diet with frequent metabolic monitoring. This diet should be continued indefinitely.

Treatment with betaine provides an alternate remethylation pathway to convert excess homocysteine into methionine and may help to prevent complications, particularly thrombosis. [13],[14] In converting homocysteine to methionine, betaine lowers the free plasma homocysteine and total homocysteine concentrations but raises the plasma concentration of methionine. Although betaine is typically provided orally at 6-9 g/day in two divided doses, its optimal dose has not been determined. [15]

Folate and vitamin B12 optimize the conversion of homocysteine to methionine by methionine synthase, thus helping to decrease the plasma homocystine concentration. When the red blood cell folate and serum B12 concentrations are reduced, folic acid is given orally at 5 mg/day and vitamin B12 is given as hydroxocobalamin at 1 mg IM per month.

As homocystinuria is a genetic disorder, frequent monitoring of blood homocysteine levels should be done and the duration of treatment should be life long. Affected individuals should be monitored at regular intervals to detect any of the clinical complications that may develop; appropriate therapy for the complications should be given as soon as possible.

Even though the diagnosis of homocysteinuria is made with the help of clinical features, it requires the estimation of homocystene in the blood as well as other biochemical tests such as the silver nitroprusside and nitroprusside tests. In our case, the homocysteine level was elevated in blood-106.62 µmol/L (normal level: 5.90-16 µmol/L) and the silver nitroprusside and nitroprusside test results were positive.

It is noteworthy that only a few cases of homocysteinuria with cutis marmorata have been reported from India, most of these cases were detected accidentally.

References
1.
Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al . The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1985;37:1-31.
[Google Scholar]
2.
Stabler SP, Steegborn C, Wahl MC, Oliveriusova J, Kraus JP, Allen RH, et al . Elevated plasma total homocysteine in severe methionine adenosyltransferase I/III deficiency. Metabolism 2002;51:981-8.
[Google Scholar]
3.
Mudd SH, Cerone R, Schiaffino MC, Fantasia AR, Minniti G, Caruso U, et al . Glycine N-methyltransferase deficiency: A novel inborn error causing persistent isolated hypermethioninaemia. J Inherit Metab Dis 2001;24:448-64.
[Google Scholar]
4.
Baric I, Fumic K, Glenn B, Cuk M, Schulze A, Finkelstein JD, et al . S-adenosylhomocysteine hydrolase deficiency in a human: A genetic disorder of methionine metabolism. Proc Natl Acad Sci U S A 2004;101:4234-9.
[Google Scholar]
5.
Grompe M. The pathophysiology and treatment of hereditary tyrosinemia type 1. Semin Liver Dis 2001:21:563-71.
[Google Scholar]
6.
Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaud et al , Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. Vol. 1. 7th ed. New York: McGraw-Hill; 1995. p. 1279-327.
[Google Scholar]
7.
Wilcken DE, Dudman NP, Tyrrell PA. Homocysteinuria due to cystathionine beta-synthase deficiency--the effects of betaine treatment in pyridoxine-responsive patients. Metabolism 1985;34:1115-21.
[Google Scholar]
8.
Kang SS, Wong PW, Cook HY, Norusis M, Messer JV. Protein-bound homocyst(e)ine: A possible risk factor for coronary artery disease. J Clin Invest 1986;77:1482-6.
[Google Scholar]
9.
Tsai MY, Bignell M, Schwichtenberg K, Hanson NQ. High prevalence of a mutation in the cystathionine beta-synthase gene. Am J Hum Genet 1996;59:1262-7.
[Google Scholar]
10.
Chao CL, Tsai HH, Lee CM, Hsu SM, Kao JT, Chien KL, et al . The graded effect of hyperhomocysteinemia on the severity and extent of coronary atherosclerosis. Atherosclerosis 1999;147:379-86.
[Google Scholar]
11.
Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR et al . Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 2001;345:1593-600.
[Google Scholar]
12.
Yap S, Naughten E. Homocysteinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis 1998;21:738-47.
[Google Scholar]
13.
Yap S, Boers GH, Wilcken B, Wilcken DE, Brenton DP, Lee PJ et al . Vascular outcome in patients with homocysteinuria due to cystathionine beta-synthase deficiency treated chronically: A multicenter observational study. Arterioscler Thromb Vasc Biol 2001;21:2080-5.
[Google Scholar]
14.
Lawson-Yuen A, Levy HL. The use of betadine in the treatment of elevated homocysteine. 2006 Mol Genet Metab [Epub ahead of print].
[Google Scholar]
15.
Schwahn BC, Hafner D, Hohlfeld T, Balkenhol N, Laryea MD, Wendel U. Pharmacokinetics of oral betaine in healthy subjects and patients with homocysteinuria. Br J Clin Pharmacol 2003;55:6-13.
[Google Scholar]

Fulltext Views
111

PDF downloads
36
Show Sections